Big boy breasts no big deal for J & J

Never heard of Risperdal till today but the name of this drug should enter the Horrible Drug Hall of Shame. According to a Huffington Post expose, J & J developed Risperdal in 1994 to become a profitable replacement for its standard antipsychotic drug that lost obscene profits due to generics. But J & J got greedy and expanded the 'cures' Risperdal could alleviate, including childhood conditions. Doctors grabbed the 'incentives' and turne...d Risperdal into a $3 billion a year bonanza. Unfortunately, one of its many side effects was that over 5% of boy customers developed breasts, some of them rivaling Dolly Parton's. J & J slapped a restrictive corporate bra on the unfortunate data till investigators unhooked the cover up. Eventually J & J pleaded guilty to criminal charges and paid over $6 billion in fines and big boy breast settlements. Not to worry as Risperdal made $18 billion in profits, winning the CEO job for chief Risperdal marketer, Alex Gorsky. Oh yes, Gorsky made $25 mil last year.

Come to think of it, if they do vote Risperdal into the Horrible Drug Hall of Shame, they should change its name to 46DD. That's the biggest breast size an unfortunate young male victim developed.